ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
75 hedge funds and large institutions have $12.6M invested in Oncternal Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 17 increasing their positions, 22 reducing their positions, and 24 closing their positions.
Holders
75
Holders Change
-4
Holders Change %
-5.06%
% of All Funds
1.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
17
Reduced
22
Closed
24
Calls
$92K
Puts
$115K
Net Calls
-$23K
Net Calls Change
+$106K
Top Buyers
1 |
1
Citadel Advisors
Miami,
Florida
|
$1.29M |
2 |
2
Millennium Management
New York
|
$1.44M |
3 |
BC
3
BIT Capital
Berlin,
Germany
|
$453K |
4 |
E
4
Ergoteles
New York
|
$237K |
5 |
5
UBS Group
Zurich,
Switzerland
|
$184K |